Quest Diagnostics Incorporated
DGX
Cena:
$ 195.09
+1.27 (0.66%)
Valuace
26
Růst
31
Zdraví
72
Akcionáři
Akcionáři společnosti
Insider trading
Akcionáři společnosti
| Držitel | Počet akcií | Podíl společnosti | Změna % | Váha pozice v portfoliu | Prvně nakoupeno |
|---|---|---|---|---|---|
| VANGUARD GROUP INC | 14.4 mil | 12.97% | 0.00% | 0.04% | 2005-03-31 |
| BLACKROCK FUNDING, INC. /DE | 10.1 mil | 9.12% | 0.00% | 0.03% | 2024-09-30 |
| BLACKROCK INC. | 10.1 mil | 9.06% | 0.00% | 0.03% | 2013-06-30 |
| BLACKROCK, INC. | 9.2 mil | 8.26% | 0.00% | 0.03% | 2024-09-30 |
| PRICE T ROWE ASSOCIATES INC /MD/ | 6.3 mil | 5.67% | 0.02% | 0.14% | 2007-06-30 |
| 6.1 mil | 5.48% | 0.06% | 0.06% | 2026-03-31 | |
| STATE STREET CORP | 5.4 mil | 4.85% | 0.01% | 0.04% | 2013-06-30 |
| BOSTON PARTNERS | 4.0 mil | 3.61% | 0.12% | 0.82% | 2025-03-31 |
| JPMORGAN CHASE & CO | 3.8 mil | 3.47% | 0.00% | 0.05% | 2013-06-30 |
| GEODE CAPITAL MANAGEMENT, LLC | 3.1 mil | 2.78% | 0.01% | 0.04% | 2006-09-30 |
| MORGAN STANLEY | 2.5 mil | 2.23% | 0.00% | 0.03% | 2013-06-30 |
| EDGEPOINT INVESTMENT GROUP INC. | 2.2 mil | 2.02% | 1.16% | 3.53% | 2025-06-30 |
| DIMENSIONAL FUND ADVISORS LP | 1.9 mil | 1.76% | 0.01% | 0.08% | 2013-06-30 |
| GRANTHAM, MAYO, VAN OTTERLOO & CO. LLC | 1.9 mil | 1.70% | 0.14% | 0.94% | 2020-03-31 |
| VICTORY CAPITAL MANAGEMENT INC | 1.8 mil | 1.66% | 0.02% | 0.23% | 2015-06-30 |
| WELLS FARGO & COMPANY/MN | 1.8 mil | 1.59% | 0.01% | 0.07% | 2011-12-31 |
| BANK OF AMERICA CORP /DE/ | 1.8 mil | 1.58% | 0.00% | 0.03% | 2013-03-31 |
| INVESCO LTD. | 1.6 mil | 1.48% | 0.00% | 0.05% | 2011-12-31 |
| DAVIS SELECTED ADVISERS | 1.6 mil | 1.46% | 0.22% | 1.46% | 2014-03-31 |
| WELLINGTON MANAGEMENT GROUP LLP | 1.4 mil | 1.29% | 0.00% | 0.05% | 2014-03-31 |
| GOLDMAN SACHS GROUP INC | 1.3 mil | 1.22% | -0.01% | 0.03% | 2007-12-31 |
| NORGES BANK | 1.3 mil | 1.19% | 0.02% | 0.02% | 2025-12-31 |
| NORDEA INVESTMENT MANAGEMENT AB | 1.3 mil | 1.13% | 0.14% | 0.22% | 2005-09-30 |
| NORTHERN TRUST CORP | 1.1 mil | 1.00% | 0.01% | 0.03% | 2013-06-30 |
| FMR LLC | 942.22 tis | 0.85% | 0.00% | 0.01% | 2008-09-30 |
| AMERICAN CENTURY COMPANIES INC | 867.33 tis | 0.78% | 0.01% | 0.09% | 2013-06-30 |
| UBS ASSET MANAGEMENT AMERICAS INC | 846.60 tis | 0.76% | 0.00% | 0.03% | 2003-09-30 |
| AMERIPRISE FINANCIAL INC | 807.48 tis | 0.73% | 0.00% | 0.04% | 2012-06-30 |
| M&G PLC | 805.34 tis | 0.73% | -0.03% | 0.82% | 2024-03-31 |
| CHARLES SCHWAB INVESTMENT MANAGEMENT INC | 760.79 tis | 0.69% | 0.00% | 0.02% | 2001-03-31 |
| DEKABANK DEUTSCHE GIROZENTRALE | 748.68 tis | 0.67% | 0.05% | 0.25% | 2009-12-31 |
| LEGAL & GENERAL GROUP PLC | 736.63 tis | 0.66% | 0.00% | 0.03% | 2007-06-30 |
| QUBE RESEARCH & TECHNOLOGIES LTD | 734.71 tis | 0.66% | 0.03% | 0.16% | 2023-03-31 |
| FIDUCIARY MANAGEMENT INC /WI/ | 720.99 tis | 0.65% | -0.24% | 1.75% | 2024-03-31 |
| UBS GROUP AG | 702.34 tis | 0.63% | -0.01% | 0.02% | 2014-12-31 |
| NUANCE INVESTMENTS, LLC | 681.64 tis | 0.61% | 0.48% | 2.38% | 2023-12-31 |
| ALLIANCEBERNSTEIN L.P. | 681.16 tis | 0.61% | 0.00% | 0.04% | 2010-12-31 |
| BESSEMER GROUP INC | 660.48 tis | 0.60% | -0.08% | 0.16% | 2013-06-30 |
| BANK OF NEW YORK MELLON CORP | 655.96 tis | 0.59% | 0.00% | 0.02% | 2009-09-30 |
| MILLENNIUM MANAGEMENT LLC | 653.77 tis | 0.58% | 0.04% | 0.05% | 2007-06-30 |
| VANGUARD FIDUCIARY TRUST CO | 619.18 tis | 0.56% | 0.03% | 0.03% | 2026-03-31 |
| WOODLINE PARTNERS LP | 593.74 tis | 0.53% | 0.21% | 0.44% | 2024-03-31 |
| BARCLAYS PLC | 565.47 tis | 0.51% | 0.01% | 0.03% | 2013-06-30 |
| MARSHALL WACE, LLP | 557.16 tis | 0.50% | 0.07% | 0.11% | 2016-06-30 |
| DEUTSCHE BANK AG\ | 550.90 tis | 0.50% | 0.00% | 0.04% | 2013-09-30 |
| HSBC HOLDINGS PLC | 536.27 tis | 0.48% | -0.02% | 0.04% | 2012-03-31 |
| PRINCIPAL FINANCIAL GROUP INC | 526.03 tis | 0.47% | 0.01% | 0.06% | 2005-12-31 |
| NEUBERGER BERMAN GROUP LLC | 518.50 tis | 0.46% | -0.03% | 0.07% | 2015-03-31 |
| 8 KNOTS MANAGEMENT, LLC | 497.61 tis | 0.45% | 0.21% | 6.58% | 2024-03-31 |
| RTW INVESTMENTS, LP | 500.00 tis | 0.45% | 1.02% | 1.28% | 2025-03-31 |
| CRAWFORD INVESTMENT COUNSEL INC | 486.43 tis | 0.44% | 0.19% | 1.63% | 2024-03-31 |
| RENAISSANCE TECHNOLOGIES LLC | 487.46 tis | 0.44% | -0.01% | 0.10% | 2016-12-31 |
| ROYAL BANK OF CANADA | 472.23 tis | 0.42% | -0.01% | 0.01% | 2013-06-30 |
| NUVEEN, LLC | 465.43 tis | 0.42% | 0.01% | 0.02% | 2025-03-31 |
| RAYMOND JAMES FINANCIAL INC | 458.46 tis | 0.41% | 0.00% | 0.03% | 2024-12-31 |
| ARTEMIS INVESTMENT MANAGEMENT LLP | 447.27 tis | 0.40% | -0.04% | 0.93% | 2025-06-30 |
| PACER ADVISORS, INC. | 447.73 tis | 0.40% | -0.02% | 0.20% | 2015-12-31 |
| ABRDN PLC | 434.18 tis | 0.39% | -0.01% | 0.12% | 2017-09-30 |
| ENVESTNET ASSET MANAGEMENT INC | 412.44 tis | 0.37% | 0.00% | 0.02% | 2013-06-30 |
| AMUNDI | 408.33 tis | 0.37% | 0.00% | 0.02% | 2021-06-30 |
| VOYA INVESTMENT MANAGEMENT LLC | 403.61 tis | 0.36% | 0.07% | 0.07% | 2013-06-30 |
| BALYASNY ASSET MANAGEMENT L.P. | 393.06 tis | 0.35% | 0.09% | 0.09% | 2024-06-30 |
| M&G INVESTMENT MANAGEMENT LTD | 375.70 tis | 0.34% | -0.03% | 0.18% | 2019-12-31 |
| ALYESKA INVESTMENT GROUP, L.P. | 375.00 tis | 0.33% | 0.34% | 0.34% | 2023-12-31 |
| BNP PARIBAS ARBITRAGE, SNC | 367.33 tis | 0.33% | -0.01% | 0.04% | 2013-09-30 |
| APG ASSET MANAGEMENT N.V. | 363.45 tis | 0.33% | 0.01% | 0.08% | 2013-06-30 |
| MACQUARIE GROUP LTD | 358.11 tis | 0.32% | 0.00% | 0.06% | 2013-03-31 |
| CALIFORNIA PUBLIC EMPLOYEES RETIREMENT SYSTEM | 350.25 tis | 0.32% | 0.00% | 0.03% | 2011-09-30 |
| CITADEL ADVISORS LLC | 347.22 tis | 0.31% | 0.00% | 0.01% | 2017-06-30 |
| SQUAREPOINT OPS LLC | 345.79 tis | 0.31% | -0.02% | 0.08% | 2017-06-30 |
| VAN LANSCHOT KEMPEN INVESTMENT MANAGEMENT N.V. | 341.65 tis | 0.31% | -0.12% | 0.58% | 2024-06-30 |
| PRUDENTIAL FINANCIAL INC | 332.74 tis | 0.30% | -0.02% | 0.07% | 2004-12-31 |
| FIRST TRUST ADVISORS LP | 329.15 tis | 0.30% | 0.00% | 0.05% | 2013-06-30 |
| D. E. SHAW & CO., INC. | 328.73 tis | 0.30% | 0.03% | 0.03% | 2025-12-31 |
| ADVISORS CAPITAL MANAGEMENT, LLC | 327.25 tis | 0.29% | 0.11% | 0.75% | 2017-03-31 |
| SWISS NATIONAL BANK | 326.50 tis | 0.29% | 0.01% | 0.04% | 2013-06-30 |
| ROBECO INSTITUTIONAL ASSET MANAGEMENT B.V. | 325.08 tis | 0.29% | -0.06% | 0.09% | 2008-06-30 |
| NUVEEN ASSET MANAGEMENT, LLC | 326.40 tis | 0.29% | 0.00% | 0.01% | 2016-12-31 |
| PICTET ASSET MANAGEMENT HOLDING SA | 319.46 tis | 0.29% | 0.01% | 0.06% | 2023-09-30 |
| BAHL & GAYNOR INC | 314.86 tis | 0.28% | 0.05% | 0.27% | 2016-03-31 |
| LSV ASSET MANAGEMENT | 315.32 tis | 0.28% | -0.03% | 0.09% | 2012-06-30 |
| GREAT WEST LIFE ASSURANCE CO /CAN/ | 305.69 tis | 0.28% | 0.01% | 0.11% | 2010-06-30 |
| CAUSEWAY CAPITAL MANAGEMENT LLC | 304.48 tis | 0.27% | -0.26% | 1.05% | 2023-06-30 |
| ALLIANZ ASSET MANAGEMENT GMBH | 304.36 tis | 0.27% | -0.02% | 0.07% | 2013-06-30 |
| M.D. SASS, INC. | 299.46 tis | 0.27% | 4.45% | 4.45% | 2026-03-31 |
| SCHRODER INVESTMENT MANAGEMENT GROUP | 295.04 tis | 0.27% | 0.01% | 0.05% | 2013-06-30 |
| CITIGROUP INC | 287.12 tis | 0.26% | 0.00% | 0.02% | 1999-03-31 |
| RHUMBLINE ADVISERS | 288.29 tis | 0.26% | 0.00% | 0.04% | 2013-06-30 |
| SUMITOMO MITSUI TRUST HOLDINGS, INC. | 285.12 tis | 0.25% | 0.00% | 0.03% | 2011-12-31 |
| WEDGE CAPITAL MANAGEMENT L L P/NC | 277.56 tis | 0.25% | 0.59% | 0.67% | 2013-09-30 |
| SEI INVESTMENTS CO | 279.11 tis | 0.25% | 0.00% | 0.05% | 2014-12-31 |
| BANK OF MONTREAL /CAN/ | 277.40 tis | 0.25% | 0.01% | 0.02% | 2013-06-30 |
| DZ BANK AG DEUTSCHE ZENTRAL GENOSSENSCHAFTS BANK, FRANKFURT AM MAIN | 275.21 tis | 0.25% | -0.01% | 0.04% | 2021-12-31 |
| ADAGE CAPITAL PARTNERS GP, L.L.C. | 269.11 tis | 0.24% | 0.03% | 0.07% | 2017-12-31 |
| AQR CAPITAL MANAGEMENT LLC | 263.34 tis | 0.24% | 0.03% | 0.06% | 2015-03-31 |
| CREDIT SUISSE AG/ | 244.72 tis | 0.22% | 0.00% | 0.03% | 2013-03-31 |
| HEARTLAND ADVISORS INC | 227.97 tis | 0.21% | 0.29% | 1.75% | 2010-12-31 |
Insider trading
| Jméno | Pozice | Typ transakce | Počet převedených akcií | Průměrná cena akcie | Datum | Počet držených akcií |
|---|---|---|---|---|---|---|
| DELANEY MARK E | officer: SVP & Chief Commercial Officer | L-Small | 37 | 194.70 | 24.4 2026 | 11901 |
| KUPPUSAMY KARTHIK | officer: SVP, Clinical Solutions | L-Small | 39 | 194.70 | 24.4 2026 | 13490 |
| Lassiter Wright III | director | L-Small | 6 | 194.70 | 24.4 2026 | 9063 |
| CARTER ROBERT B | director | L-Small | 7 | 194.70 | 24.4 2026 | 2711 |
| Gregg Vicky B | director | A-Award | 68 | 194.70 | 24.4 2026 | 17172 |
| Plewman Patrick | officer: SVP for Diagnostic Services | L-Small | 49 | 194.70 | 24.4 2026 | 15247 |
| SAMAD SAM | officer: Executive Vice President & CFO | A-Award | 108 | 194.70 | 24.4 2026 | 33376 |
| WENTWORTH TIMOTHY C | director | A-Award | 198 | 0.00 | 2.4 2026 | 198 |
| WENTWORTH TIMOTHY C | director: | 0 | 0.00 | 11.3 2026 | 0 | |
| WENTWORTH TIMOTHY C | director | A-Award | 215 | 0.00 | 11.3 2026 | 215 |
| KUPPUSAMY KARTHIK | officer: SVP, Clinical Solutions | S-Sale | 2628 | 204.86 | 6.3 2026 | 13441 |
| KUPPUSAMY KARTHIK | officer: SVP, Clinical Solutions | A-Award | 6200 | 204.86 | 6.3 2026 | 16069 |
| Deppe Michael J | officer: SVP, Corp. Controller & CAO | F-InKind | 750 | 204.86 | 6.3 2026 | 35196 |
| Deppe Michael J | officer: SVP, Corp. Controller & CAO | A-Award | 1473 | 204.86 | 6.3 2026 | 35946 |
| Plewman Patrick | officer: SVP for Diagnostic Services | S-Sale | 2855 | 206.21 | 6.3 2026 | 15198 |
| Plewman Patrick | officer: SVP for Diagnostic Services | F-InKind | 2827 | 204.86 | 6.3 2026 | 18053 |
| Plewman Patrick | officer: SVP for Diagnostic Services | A-Award | 5682 | 204.86 | 6.3 2026 | 20880 |
| Davis J. E. | director, officer: CEO and President | F-InKind | 26414 | 204.86 | 6.3 2026 | 142423 |
| Davis J. E. | director, officer: CEO and President | A-Award | 51652 | 204.86 | 6.3 2026 | 168837 |
| PREVOZNIK MICHAEL E | officer: SVP & General Counsel | S-Sale | 3878 | 206.21 | 6.3 2026 | 37557 |
| PREVOZNIK MICHAEL E | officer: SVP & General Counsel | F-InKind | 3354 | 204.86 | 6.3 2026 | 41435 |
| PREVOZNIK MICHAEL E | officer: SVP & General Counsel | A-Award | 7232 | 204.86 | 6.3 2026 | 44789 |
| DELANEY MARK E | officer: SVP & Chief Commercial Officer | F-InKind | 2326 | 204.86 | 6.3 2026 | 11864 |
| DELANEY MARK E | officer: SVP & Chief Commercial Officer | A-Award | 5682 | 204.86 | 6.3 2026 | 14190 |
| Doherty Catherine T. | officer: EVP, Regional Businesses | S-Sale | 5558 | 206.21 | 6.3 2026 | 67122 |
| Doherty Catherine T. | officer: EVP, Regional Businesses | F-InKind | 5806 | 204.86 | 6.3 2026 | 72680 |
| Doherty Catherine T. | officer: EVP, Regional Businesses | A-Award | 11364 | 204.86 | 6.3 2026 | 78486 |
| SAMAD SAM | officer: Executive Vice President & CFO | F-InKind | 7720 | 204.86 | 6.3 2026 | 33268 |
| SAMAD SAM | officer: Executive Vice President & CFO | A-Award | 13947 | 204.86 | 6.3 2026 | 40988 |
| Deppe Michael J | officer: SVP, Corp. Controller & CAO | F-InKind | 88 | 204.86 | 4.3 2026 | 34473 |
| DELANEY MARK E | officer: SVP & Chief Commercial Officer | F-InKind | 188 | 204.86 | 4.3 2026 | 8508 |
| KUPPUSAMY KARTHIK | officer: SVP, Clinical Solutions | F-InKind | 205 | 204.86 | 4.3 2026 | 9869 |
| Plewman Patrick | officer: SVP for Diagnostic Services | S-Sale | 410 | 207.73 | 4.3 2026 | 15198 |
| Plewman Patrick | officer: SVP for Diagnostic Services | F-InKind | 230 | 204.86 | 4.3 2026 | 15608 |
| Davis J. E. | director, officer: CEO and President | S-Sale | 10000 | 212.52 | 4.3 2026 | 117185 |
| Davis J. E. | director, officer: CEO and President | F-InKind | 2968 | 204.86 | 4.3 2026 | 127185 |
| PREVOZNIK MICHAEL E | officer: SVP & General Counsel | S-Sale | 526 | 207.73 | 4.3 2026 | 37557 |
| PREVOZNIK MICHAEL E | officer: SVP & General Counsel | F-InKind | 288 | 204.86 | 4.3 2026 | 38083 |
| SAMAD SAM | officer: Executive Vice President & CFO | F-InKind | 869 | 204.86 | 4.3 2026 | 27041 |
| Doherty Catherine T. | officer: EVP, Regional Businesses | S-Sale | 632 | 207.73 | 4.3 2026 | 67122 |
| Doherty Catherine T. | officer: EVP, Regional Businesses | F-InKind | 648 | 204.86 | 4.3 2026 | 67754 |
| Gregg Vicky B | director | L-Small | 67 | 183.51 | 20.2 2026 | 17104 |
| CARTER ROBERT B | director | L-Small | 6 | 183.51 | 20.2 2026 | 2704 |
| Lassiter Wright III | director | L-Small | 7 | 183.51 | 20.2 2026 | 9057 |
| Deppe Michael J | officer: SVP, Corp. Controller & CAO | A-Award | 1688 | 204.96 | 20.2 2026 | 1688 |
| Deppe Michael J | officer: SVP, Corp. Controller & CAO | F-InKind | 99 | 206.99 | 20.2 2026 | 34560 |
| Deppe Michael J | officer: SVP, Corp. Controller & CAO | F-InKind | 83 | 210.01 | 20.2 2026 | 34659 |
| Deppe Michael J | officer: SVP, Corp. Controller & CAO | A-Award | 366 | 0.00 | 20.2 2026 | 34742 |
| DELANEY MARK E | officer: SVP & Chief Commercial Officer | A-Award | 7332 | 204.96 | 20.2 2026 | 7332 |
| DELANEY MARK E | officer: SVP & Chief Commercial Officer | F-InKind | 230 | 206.99 | 20.2 2026 | 8681 |
| DELANEY MARK E | officer: SVP & Chief Commercial Officer | L-Small | 15 | 183.51 | 20.2 2026 | 8696 |
| DELANEY MARK E | officer: SVP & Chief Commercial Officer | F-InKind | 205 | 210.01 | 20.2 2026 | 8911 |
| DELANEY MARK E | officer: SVP & Chief Commercial Officer | A-Award | 1586 | 0.00 | 20.2 2026 | 9116 |
| KUPPUSAMY KARTHIK | officer: SVP, Clinical Solutions | F-InKind | 259 | 206.99 | 20.2 2026 | 7914 |
| KUPPUSAMY KARTHIK | officer: SVP, Clinical Solutions | F-InKind | 252 | 210.01 | 20.2 2026 | 8173 |
| KUPPUSAMY KARTHIK | officer: SVP, Clinical Solutions | A-Award | 9853 | 204.96 | 20.2 2026 | 9853 |
| KUPPUSAMY KARTHIK | officer: SVP, Clinical Solutions | A-Award | 2135 | 0.00 | 20.2 2026 | 10049 |
| KUPPUSAMY KARTHIK | officer: SVP, Clinical Solutions | L-Small | 16 | 183.52 | 20.2 2026 | 10065 |
| Doherty Catherine T. | officer: EVP, Regional Businesses | A-Award | 13514 | 204.96 | 20.2 2026 | 13514 |
| Doherty Catherine T. | officer: EVP, Regional Businesses | S-Sale | 1433 | 204.83 | 20.2 2026 | 68402 |
| Doherty Catherine T. | officer: EVP, Regional Businesses | F-InKind | 728 | 206.99 | 20.2 2026 | 69835 |
| Doherty Catherine T. | officer: EVP, Regional Businesses | F-InKind | 433 | 210.01 | 20.2 2026 | 70563 |
| Doherty Catherine T. | officer: EVP, Regional Businesses | A-Award | 2928 | 0.00 | 20.2 2026 | 70996 |
| Davis J. E. | director, officer: CEO and President | A-Award | 73225 | 204.96 | 20.2 2026 | 73225 |
| Davis J. E. | director, officer: CEO and President | F-InKind | 3788 | 206.99 | 20.2 2026 | 130153 |
| Davis J. E. | director, officer: CEO and President | F-InKind | 2396 | 210.01 | 20.2 2026 | 133941 |
| Davis J. E. | director, officer: CEO and President | A-Award | 15857 | 0.00 | 20.2 2026 | 136337 |
| PREVOZNIK MICHAEL E | officer: SVP & General Counsel | A-Award | 9289 | 204.96 | 20.2 2026 | 9289 |
| PREVOZNIK MICHAEL E | officer: SVP & General Counsel | S-Sale | 1111 | 204.83 | 20.2 2026 | 38371 |
| PREVOZNIK MICHAEL E | officer: SVP & General Counsel | F-InKind | 347 | 206.99 | 20.2 2026 | 39482 |
| PREVOZNIK MICHAEL E | officer: SVP & General Counsel | F-InKind | 301 | 210.01 | 20.2 2026 | 39829 |
| PREVOZNIK MICHAEL E | officer: SVP & General Counsel | A-Award | 2013 | 0.00 | 20.2 2026 | 40130 |
| SAMAD SAM | officer: Executive Vice President & CFO | A-Award | 18303 | 204.96 | 20.2 2026 | 18303 |
| SAMAD SAM | officer: Executive Vice President & CFO | F-InKind | 1010 | 206.99 | 20.2 2026 | 27841 |
| SAMAD SAM | officer: Executive Vice President & CFO | A-Award | 69 | 183.51 | 20.2 2026 | 27910 |
| SAMAD SAM | officer: Executive Vice President & CFO | F-InKind | 855 | 210.01 | 20.2 2026 | 28851 |
| SAMAD SAM | officer: Executive Vice President & CFO | A-Award | 3965 | 0.00 | 20.2 2026 | 29706 |
| Plewman Patrick | officer: SVP for Diagnostic Services | A-Award | 9009 | 204.96 | 20.2 2026 | 9009 |
| Plewman Patrick | officer: SVP for Diagnostic Services | S-Sale | 958 | 204.83 | 20.2 2026 | 15838 |
| Plewman Patrick | officer: SVP for Diagnostic Services | F-InKind | 293 | 206.99 | 20.2 2026 | 16796 |
| Plewman Patrick | officer: SVP for Diagnostic Services | F-InKind | 244 | 210.01 | 20.2 2026 | 17089 |
| Plewman Patrick | officer: SVP for Diagnostic Services | A-Award | 1952 | 0.00 | 20.2 2026 | 17333 |
| Doherty Catherine T. | officer: EVP, Regional Businesses | M-Exempt | 26165 | 112.17 | 17.2 2026 | 0 |
| Doherty Catherine T. | officer: EVP, Regional Businesses | S-Sale | 351 | 209.10 | 17.2 2026 | 68068 |
| Doherty Catherine T. | officer: EVP, Regional Businesses | S-Sale | 1619 | 208.21 | 17.2 2026 | 68419 |
| Doherty Catherine T. | officer: EVP, Regional Businesses | S-Sale | 3500 | 207.08 | 17.2 2026 | 70038 |
| Doherty Catherine T. | officer: EVP, Regional Businesses | S-Sale | 10122 | 206.37 | 17.2 2026 | 73538 |
| Doherty Catherine T. | officer: EVP, Regional Businesses | S-Sale | 10573 | 205.21 | 17.2 2026 | 83660 |
| Doherty Catherine T. | officer: EVP, Regional Businesses | M-Exempt | 26165 | 112.17 | 17.2 2026 | 94233 |
| Plewman Patrick | officer: SVP for Diagnostic Services | M-Exempt | 5662 | 121.81 | 12.2 2026 | 0 |
| Plewman Patrick | officer: SVP for Diagnostic Services | A-Award | 48 | 183.51 | 12.2 2026 | 15381 |
| Plewman Patrick | officer: SVP for Diagnostic Services | S-Sale | 5662 | 204.00 | 12.2 2026 | 15381 |
| Plewman Patrick | officer: SVP for Diagnostic Services | M-Exempt | 5662 | 121.81 | 12.2 2026 | 21043 |
| Gregg Vicky B | director | S-Sale | 1250 | 191.76 | 28.11 2025 | 17037 |
| Davis J. E. | director, officer: CEO and President | M-Exempt | 55093 | 95.80 | 28.11 2025 | 0 |
| Davis J. E. | director, officer: CEO and President | S-Sale | 4747 | 192.97 | 28.11 2025 | 120480 |
| Davis J. E. | director, officer: CEO and President | S-Sale | 41004 | 192.27 | 28.11 2025 | 125227 |
| Davis J. E. | director, officer: CEO and President | S-Sale | 9342 | 191.59 | 28.11 2025 | 166231 |
| Davis J. E. | director, officer: CEO and President | M-Exempt | 55093 | 95.80 | 28.11 2025 | 175573 |
| DELANEY MARK E | officer: SVP & Chief Commercial Officer | M-Exempt | 100 | 143.33 | 20.11 2025 | 15476 |
